The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis ; volume:18 ; number:1 ; day:26 ; month:6 ; year:2017 ; pages:1-8 ; date:12.2017
Respiratory research ; 18, Heft 1 (26.6.2017), 1-8, 12.2017
- Schlagwort
-
Atemwegskrankheit
Atemnot
- Urheber
-
Barry, L. E.
- Beteiligte Personen und Organisationen
-
Sweeney, J.
O’Neill, C.
Price, D.
Heaney, L. G.
SpringerLink (Online service)
- DOI
-
10.1186/s12931-017-0614-x
- URN
-
urn:nbn:de:1111-201709213869
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Barry, L. E.
- Sweeney, J.
- O’Neill, C.
- Price, D.
- Heaney, L. G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nebulized budesonide combined with systemic corticosteroid vs systemic corticosteroid alone in acute severe asthma managed in the emergency department: a randomized controlled trial
Correction: Nebulized budesonide combined with systemic corticosteroid vs systemic corticosteroid alone in acute severe asthma managed in the emergency department: a randomized controlled trial
Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma
Serum prednisolone levels as a marker of oral corticosteroid adherence in severe asthma
Corticosteroid suppression of lipoxin A4 and leukotriene B4from alveolar macrophages in severe asthma
Asthma Exacerbations in Severe Asthma: Why Systemic Corticosteroids May not Always Be the Best Treatment Option
Severe asthma in childhood
Dexamethasone – A Corticosteroid Reduces Death in Severe COVID-19
Morbidity associated with systemic corticosteroid preparation for coronary artery bypass grafting in patients with chronic obstructive pulmonary disease: a case control study
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial
Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry
SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
Nebulized budesonide combined with systemic corticosteroid vs systemic corticosteroid alone in acute severe asthma managed in the emergency department: a randomized controlled trial
Correction: Nebulized budesonide combined with systemic corticosteroid vs systemic corticosteroid alone in acute severe asthma managed in the emergency department: a randomized controlled trial
Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma
Serum prednisolone levels as a marker of oral corticosteroid adherence in severe asthma
Corticosteroid suppression of lipoxin A4 and leukotriene B4from alveolar macrophages in severe asthma
Asthma Exacerbations in Severe Asthma: Why Systemic Corticosteroids May not Always Be the Best Treatment Option
Severe asthma in childhood
Dexamethasone – A Corticosteroid Reduces Death in Severe COVID-19
Morbidity associated with systemic corticosteroid preparation for coronary artery bypass grafting in patients with chronic obstructive pulmonary disease: a case control study
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial
Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry
SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
Nebulized budesonide combined with systemic corticosteroid vs systemic corticosteroid alone in acute severe asthma managed in the emergency department: a randomized controlled trial
Correction: Nebulized budesonide combined with systemic corticosteroid vs systemic corticosteroid alone in acute severe asthma managed in the emergency department: a randomized controlled trial
Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma
Serum prednisolone levels as a marker of oral corticosteroid adherence in severe asthma
Corticosteroid suppression of lipoxin A4 and leukotriene B4from alveolar macrophages in severe asthma
Asthma Exacerbations in Severe Asthma: Why Systemic Corticosteroids May not Always Be the Best Treatment Option
Severe asthma in childhood
Dexamethasone – A Corticosteroid Reduces Death in Severe COVID-19
Morbidity associated with systemic corticosteroid preparation for coronary artery bypass grafting in patients with chronic obstructive pulmonary disease: a case control study
A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial
Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry